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ABSTRACT
RNA interference (RNAi) has become an invaluable
tool for functional genomics. A critical use of this
tool depends on an understanding of the factors
thatdeterminethespecificityandactivityoftheactive
agent, small interfering RNA (siRNA). Several studies
have concluded that tolerance of mutations can be
considerable and hence lead to off-target effects. In
this study, we have investigated in vivo the toleration
of wobble (G:U) mutations in high activity siRNAs
against Flap Endonuclease 1 (Fen1) and Aquaporin-
4(Aqp4).Mutationsinthecentralpartoftheantisense
strand caused a pronounced decrease in activity,
while mutations in the 50 and 30ends were tolerated
very well. Furthermore, based on analysis of nine dif-
ferent mutated siRNAs with widely differing intrinsic
activities, we conclude that siRNA activity can be sig-
nificantly enhanced by wobble mutations (relative
to mRNA), in the 50 terminal of the antisense strand.
These findings should facilitate design of active
siRNAs where the target mRNA offers limited choice
of siRNA positions.
INTRODUCTION
Downregulation of mRNA transcripts by RNA interference
(RNAi) and short interfering RNA (siRNA) (1) has been adop-
ted as an invaluable research tool and holds promise as a novel
principle for drug development (2). Until recently, the active
agent, siRNA, has been considered as exquisitely speciﬁc
(3,4). However, there is now a growing appreciation that
the technique has limitations with regard to siRNA speciﬁcity
(5,6) and that better procedures are needed for the identiﬁca-
tion of active siRNA positions (5,7–9).
Haley and Zamore demonstrated that in Drosophila
extracts the RISC enzyme could tolerate many more muta-
tions in the 30 end of the antisense strand than in the 50 end
(10). Together with similar observations from microRNA
investigations (11–13), and microarray investigations of
off-target effects (14), this has given rise to a consensus
view in the ﬁeld that siRNA-target recognition is initiated
(or ‘seeded’) by a short section of the 50 end of the antisense
strand. However, the relevance of these studies for in vivo
RNAi in mammalian cells is in some doubt. Microarray ana-
lyses and other approaches that have been used to evaluate
the speciﬁcity of RNA interference have led to divergent
conclusions by different groups (14–17). It is still unclear
whether the siRNA and microRNA mechanisms are identical
at the mechanistic level, although there are great similarities.
The relevance of mutation studies performed in vitro in
Drosophila lysates to the in vivo situation in mammals
remains to be established. In particular, the mutations that
were shown to be tolerated by Haley and Zamore slowed
down the process considerably (from 80% target depletion
in 15 s with perfect complementarity to 24 h for obtaining
activity with a strand with multiple mutations at the 30 end).
This raises the question whether this biochemical in vitro
activity is irrelevant in vivo, where the speed of mRNA
production and RNAi mRNA depletion has been shown to
be ﬁnely balanced (5,18).
However, it is clear that some mutations and chemical
modiﬁcations in a siRNA can be well tolerated in vivo
(6,19). Furthermore, various siRNAs have the ability to
cross-react with targets of partial sequence similarity (11)
and might even non-speciﬁcally stimulate or repress hundreds
of genes involved in cellular functions (12). The mechanisms
ofthese effects are unknown, as none ofthe microarrayexperi-
ments that exposed off-target effects have been followed up
with publications validating the direct interactions between
RNAi/siRNA and the target mRNA.
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speciﬁc and highly active siRNAs (20,21). Such approaches
require knowledge of the mutation tolerance of different posi-
tions in the siRNA. Our previous studies have established that
mismatches can be tolerated in certain cases (5). Furthermore,
the position of the mismatch in the siRNA affects the severity
of silencing loss (6).
Zamore and coworkers have performed a groundbreaking
study on the architecture of the siRNA duplex in the RISC
complex of cell-free Drosophila embryo lysates (22). The
strand to be removed from the RISC complex was found to
be selected on the basis of the sequence composition in the
ﬁrst 5 and last 5 bp of the siRNA duplex. Several algorithms
for effective siRNA design have also focused on these sets of
basepairs (20). Other explanation models for inactive siRNAs
exist, among them mRNA restraints (23), and RISC enzyme
restoration after cleavage (18). Furthermore, it is possible that
the mRNA nuclease, which may be identical to Argonaute2
(24), might have preferences for certain nucleotides at the
cleavage point, as is known to be the case for other RNA
endonucleases (25).
In this work, we systematically introduced wobble-
mutations in the siRNA, leading to G:U interactions between
the siRNA antisense strand and the mRNA target. The results
show that in many cases such wobble mutations are very well
tolerated. In other cases there is less toleration, in particular if
wobble mutations are made in central regions of the siRNA.
Interestingly, wobble mutations in the terminal nucleotide of a
series of low and high activity siRNAs increased the silencing
capacity. This is the ﬁrst demonstration of such an enhancing
effect in mammalian cells in vivo. Our ﬁndings should offer
opportunities for the development of high activity siRNAs
even in cases where there are limited numbers of available
positions.
MATERIALS AND METHODS
Preparation of siRNAs
The 21mer single-stranded RNAs were synthesized at 20 nmol
scale by Ambion (Austin, TX). The RNA strands were resus-
pended in nuclease-free water (Ambion), and the concentra-
tion of the strands was veriﬁed by spectrometry using
NanoDrop (Saveen Werner).
Annealing of the complementary strands was performed by
mixing equal amounts of RNA followed by heating of the
mixture to 65 C for 5 min and cooling to room temperature
>5 min. Successful annealing of siRNA was veriﬁed by non-
denaturing 12% PAGE, staining with SYBRgold (Invitrogen)
and visualization by ﬂuorescent scanning on a Typhoon 9410
(Amersham Biosciences).
Cell culture and transfections
HeLa cells were maintained in DMEM supplemented with
10% foetal calf serum (FCS) (Gibco BRL). The cells were
passaged at sub-conﬂuence and 2.5 · 10
5 cells plated 24 h
before transfection in 6-well plates. Transfections were per-
formed using 1.44 mg siRNA per well and 3.6 ml Lipofec-
tamine2000 (Invitrogen), and thus a ratio of 2.5 of
Lipofectamine2000 to RNA (in microliters of Lipofectam-
ine2000 to micrograms of RNA), in a total volume of
200 ml, with a complexation time of 30 min. Thereafter, the
complexes were diluted to 1 ml and added onto cells. The
transfection period was 4 h, after which the transfection mix-
ture was replaced with medium.
Western blot analysis
Cells were harvested by trypsination and washed once in
serum-containing DMEM medium, and once in PBS and
the cell pellet was resuspended in a homogenization buffer
[10 mM NaPi pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% SDS,
COMPLETE Protease inhibitor cocktail (Roche 11 697 498
001), used according to the manufacturer’s protocol]. The
lysate was sonicated six times for a duration of 1 s. The lysate
was then spun for 10 min at 15 000 g and the supernatant
transferred to a new microcentrifuge tube. Total protein was
determined by DC protein assay (Bio-Rad) based on the
Lowry assay. Western blot analysis was performed using
XCell SureLock Mini-Cell and XCell II Blot Module Kit
(Invitrogen): equal amounts of protein were loaded on a
1.0 mm pre-cast 10% Bis-Tris gel (Invitrogen) and separated
by electrophoresis at 200 V for 50 min, and thereafter elec-
troblotted onto PVDF membranes (Invitrogen) at 30 V for
60 min. Equal loading amounts were veriﬁed after blotting
by Coomassie G-250 (Bio-Rad) staining of the gels. Mem-
branes were blocked with 5% non-fat dried milk powder
(AppliChem) in TBST (0.05% Tween-20) for 60 min. Incuba-
tion with primary antibodies (rabbit-anti-Fen1 from Bethyl
Laboratories, BL587, at 0.05 mg/ml, or with mouse-anti-
GAPDH from Abcam ab9484, at 0.2 mg/ml) was performed
in 2.5% non-fat dried milk powder and TBST at room tem-
perature for 3 h. Membranes were washed three times for
10 min in TBST and then incubated for 1 h with alkaline-
phosphatase linked anti-rabbit (Amersham RPN 5783) or
alkaline-phosphatase linked anti-mouse (Amersham RPN
5781) diluted 1:10 000 in 1.25% non-fat dried milk powder
and TBST. Membranes were then washed three times for
10 min in TBST. Signals were visualized by ECF (Amersham)
according to the manufacturer’s protocol. Membranes were
scanned using a Typhoon 9410 scanner and images processed
with ImageQuant TL.
Cotransfection assays
The cotransfection assays were performed using Lipofectam-
ine2000 (Invitrogen) in triplicate in 12-well plates with 100 ng
plasmid DNA and 220 ng siRNA per well. The nucleic acids
were mixed with Lipofectamine2000 at a ratio of 2.5:1
(ml Lipofectamine2000 to mg of nucleic acids) in serum-
free medium. The complexation process was allowed to pro-
ceed for 30 min at room temperature before being diluted. The
mixture was then added onto cells washed twice with PBS and
once with serum-free medium. Luciferase activity levels were
measured in 20 ml of cell lysate 24 h after transfection using
the Dual Luciferase Assay (Promega) and a Turner 20/20
luminometer (Turner Biosystems).
Isolation of mRNA and northern blot hybridizations
The mRNA was isolated at various times after transfection
using Dynabeads oligo(dT)25 (Dynal) and then separated by
gel electrophoresis, 1.5% agarose gels containing 0.8 M form-
aldehyde, for3hat50V.Theagarosegelwasthenwashed two
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onto pre-wetted BrightStar-Plus nylon membranes (Ambion).
The Fen1 mRNA was detected using a radioactive probe cor-
responding to the protein coding region (373–1515, relative to
Fen1 mRNA accession number NM_004111), using random
priming with Rediprime II (Amersham Biosciences) and P-32
alpha-CTP (Amersham Biosciences). Hybridization was per-
formed overnight using ExpressHyb (BD Biosciences), with
four subsequent washes at room temperature and at 50 C with
WashBufferI(2·SSC + 0.05%SDS),andwithWashBufferII
(0.2· SSC + 0.1% SDS), respectively. The radioactive signals
were visualized with a Phosphor Screen and a Typhoon 9410
imager (Amersham Biosciences). Quantiﬁcation of relative
signal strength was performed with the ImageQuant software
(Nonlinear Dynamics, Amersham Biosciences).
Construction of reporter plasmids
The rat pra-Aqp4-Luc and mouse pmu-Aqp4-Luc reporter
plasmids were constructed by cloning a fragment from a
mouse cDNA corresponding to position 58–1023 in GenBank
NM_009700, and a rat cDNA corresponding to position 4–956
in GenBank RM_012825, respectively, to the luciferase plas-
mid pGL3-Control (Promega). The sequence similarity of
the two constructs in the Aqp4 cDNA region is 92% between
rat and mouse sequence. The full sequence of the two plas-
mid constructs have been submitted to GenBank [accession
numbers AY785357 (pmuAqp4-Luc) and AY785358
(praAqp4-Luc)].
RESULTS
Toleration of wobble mutations
As part of an investigation of the biological relevance of Fen1,
the gene encoding the DNA repair and replication Flap Endo-
nuclease 1 (26), we screened 10 different siRNAs (Supple-
mentary Table 1) and identiﬁed several candidates that
depleted >70% of target mRNAs at 24 h post-transfection
(T. Holen, unpublished data and Figure 1A). To identify
the superior of these good candidates, we measured the activ-
ity as early as 12 h post-transfection (data not shown). One
particular siRNA, Fe775i, caused maximum downregulation
( 80%) at this time point.
Fe775i was chosen for investigation of G:U wobble muta-
tions. Wobble mutations can be directed to an A:U pair or a
C:G pair. These conceptually mild mutations entail the loss of
one or two hydrogen bonds, respectively, and retain the spatial
geometry of the double helix. In contrast, inversions of G:C
pairs (leading to a loss of three hydrogen bonds) are hard
mutations that compromise the helical geometry (5,6). The
mutated siRNAs discussed below are shown in Figure 1B.
The ﬁrst series of mild wobble mutations targeted U:A pairs
(mRNA:siRNA) at positions 3, 7 and 10 (Figure 1B). The
results were striking. Whereas no signiﬁcant loss of activity
was found after wobble mutations at position 7 and 3, a single
wobble mutation in position 10 resulted in a dramatic loss of
activity (Figure 2). This is close to the cleavage point of the
RNAi nuclease (27).
These single wobble mutations were compared with two
siRNAs with double-wobble mutation (w3/7i and w7/10i)
and one siRNA with a triple-wobble mutation (w3/7/10i)
(Figure 1B). Consistent with the single-wobble data, w3/7i
only showed slight loss of activity, while the two siRNAs
that included a mutation in position 10 (w7/10i and w3/7/
10i) demonstrated a considerable activity loss (Figure 2).
A
B
Figure 1. Impact of wobble mutations and hard mutations on the silencing
activity of the siRNA Fe775i. (A) Northern analysis of a series of siRNAs
(complete sequence of all siRNAs are presented in Supplementary Table 1)
against Fen1 (upper panel) at 24 h post-transfection. The housekeeping gene
GAPDH is used as internal standard (lower panel) to normalize Fen1 expres-
sion.TheindividualsiRNAsusedareindicatedontopofthegelandthenumber
represents the complementary location in the Fen1 mRNA sequence. (B) Sum-
mary of Fe775i mutations. Changes from the Fe775i wild-type sequence are
indicated. Full sequences of all 18 mutated siRNAs are available in Supple-
mentary data, Table 1.
Figure 2. Tolerance of A:U to G:U wobble mutations. One representative
northern blot (above) is shown. Silencing of Fen1 expression by siRNA was
quantified by ImageQuant (Typhoon 9410), standardized to a fraction of
GAPDH expression and standard deviation calculated from three independent
experiments (below).
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by western blot
To verify the silencing capacity of the mutated siRNAs w3i
and w7i in an independent assay, we tested these siRNAs for
silencing of protein expression. A time-series of western blot
analysis for FEN1 protein demonstrated that full silencing was
established at 48 h post-transfection (data not shown). This
resultalsoindicates ahalf-lifeofthe FEN1proteinof<24h.At
48 h post-transfection, both w3i and w7i revealed silencing
comparable with the wild-type Fe775i sequence, while w10i
showed almost no activity (Figure 3). Thus the tolerance of
wobble-mutated siRNAs could be veriﬁed at the protein level.
Effects of moderate wobble mutations
Mutating an A to a G in the siRNA antisense strand leads to
the loss of only one hydrogen bond in the siRNA:mRNA
interaction. An intermediate type of mutation is formed by
mutating G:C-pairs (mRNA:siRNA), replacing three-
hydrogen bond G:C pairs with single-hydrogen bond G:U
pairs (Figure 1B). The mutations in the central part, that is,
in the second and third quartile of the FE775i antisense strand,
w9i and w16i, caused sharp drops in activity similar to w10i
(Figure 4). Again, wobble mutations at the 50 end of the anti-
sense (w6i and w2i) and the 30 end (w19i) were well tolerated
(Figure 4).
Effects of hard mutations in positions tolerating
wobble mutations
Introduction of hard mutations (resulting in C:U pairs) in
position 3 and 7 led to a pronounced loss of activity, compared
with the tolerance for wobble mutations in these positions
(Figure 4). Interestingly, hard mutations to the terminal nuc-
leotideof the antisense strand, m1Ai,m1Ci and m1Ui,were on
the other hand well tolerated (Figure 4).
Thus, different positions in siRNAs tolerate different muta-
tions to different degrees. This phenomenon might reﬂect the
enzymatic and structural characteristics of the RISC complex.
Statistical studies of large data-sets of siRNA experiments
have revealed that high-activity siRNA duplexes seem on
average to have lower pairing energy in the 50 end of the
antisense strands than have corresponding siRNA duplexes
with medium or low activity (8,9). The observed effect of
our wobble mutation (which reduces the pairing energy) is
consistent with these statistical studies, and represents the ﬁrst
direct experimental veriﬁcation of this phenomenon in vivo.
Triple mutations represent a limit to tolerance
The limit of tolerance to siRNA mutations remains to be
established and incorporated into siRNA design algorithms.
Triple-mutations seemed to exhaust most of the activity of
Fe775i (Figure 2), even when combining positions with
good tolerance (w3/7/19i and w2/3/7i) (Figure 4). That siR-
NAs tolerate a maximum of two mismatches before they lose
activity may be a property common to all or most siRNAs. If
so, speciﬁc siRNAs exist for most mRNAs, as a previous
bioinformatics study demonstrated a speciﬁcity window
between 3 and 5 mismatches for most genes (20).
Wobble mutations to the 50 terminal antisense position
can enhance siRNA activity
Our ﬁndings of weak but signiﬁcant stimulatory effect of
wobble mutations (Figure 2) and high tolerance of hard muta-
tions to the antisense 50 terminal position (Figure 4) raised the
possibility that wobbles in the 50 end of the antisense strand
actually could enhance siRNA activity.
In order to test this idea, and to further expand the scope of
our study, we decided to mutate the terminal 50 nucleotide in a
series of different siRNAs targeting Aquaporin-4 (Aqp4), a
water transport protein, the disruption of which protects
against the development of brain edema (28). From a set of
31 different siRNAs tested against Aqp4 (T. Holen, unpub-
lished data), we selected siRNAs that had a 50 C in the anti-
sense strand and a range of different intrinsic activities, from
very low (RMC466, RMC627i, RMC661i and RMC686i),
through intermediate (RAC190i, RAC427i, RMC821i and
RMC869i) to very high activity (RAC937i). Each of these
siRNAs was wobble-mutated in the 50 terminal nucleotide
of the antisense strand (Figure 5B).
The results, using a cotransfection assay of siRNAs
and luciferase-fusion reporter constructs (Figure 5A), were
Figure 4. Tolerance of G:C to G:U wobble mutationsand hard mutations.One
representative northern blot and quantification for three independent experi-
ments (as above) for Fen1 are presented and the individual siRNA used for
targeting indicated above. Silencing of Fen1 was quantified as above.
Figure3.WesternblotanalysisofFen148haftertransfection.Shownarethewesternsignals,intriplicate,fromFen1andthecontrolGAPDH.Thebandinlane1isa
40 kDa size marker.
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ing in U:G wobble) in the 50 terminal siRNA:mRNA inter-
action (w-version) improved activity compared with the
wild-type siRNA (wt-version) (Figure 5C).
Zamore’s group recently demonstrated, in cell-free assays
in Drosophila, that mutations at the ends of a siRNA duplex
canskewtheloadingoftheactive strandintotheRISCenzyme
complex (22). To take this ﬁnding into consideration, and to
A
C
D
B
Figure 5. Enhancement of siRNA activity due to wobble mutations in a series of nine different siRNAs against Aqp4. (A) A diagram of the fusion-luciferase
constructs. Shownare the insertedcDNA of mouse-Aqp4 (muAqp4)and rat-Aqp4(raAqp4)in the pGL-Control plasmid.(B) Summaryof siRNAduplex annealing
andinteractionwithmRNA.Thewobblemutationpositionsareindicated.AllsiRNAsweremutatedinthe50 terminalnucleotideontheantisensestrand(C-to-U)and
onthecomplementarynucleotide(G-to-A).ThefourRNAoligostrandsfromthemutatedversionandthewild-typeversionswerethenannealedinthefourpossible
combinations possible: wild-type sense with antisense (wt), wobble sense with antisense (w), wild-type sense annealed with wobble antisense siRNA (ww) and
wobble sense with wild-type antisense (dw). The control siRNA RMC845i was mutated (U-to-G) in the 50 terminal of the antisense strand, causing a G:A mutation
versus the mRNA). See Supplementary Table 1 for a full list of all 40 siRNA duplexes. (C) Cotransfection assay. The rat pra-Aqp4-Luc plasmid was cotransfected
with the different siRNA versions: wild-type (wt, black bars), wobble (w, red bars), wobble in both duplex and mRNA (ww, green bars) and wobble in duplex (dw,
blue bars).Each siRNAwas testedat least ninetimes,in three differentexperiments.Shownis a representative experiment,with standarddeviation,with luciferase
signalstandardizedtoapercentagefractionofaninactivecontrolsiRNA.(D)Cotransfectionassay.ThemouseAqp4plasmidpmu-Aqp4-Lucwascotransfectedwith
the indicated siRNAs (RMC-siRNAs), all of which have 100% identity (for the wild-type) to mouse cDNA.
4708 Nucleic Acids Research, 2005, Vol. 33, No. 15assess the in vivo response, each RNA strand from the new
wobble siRNAs was annealed to the corresponding strand of
the wild-type siRNA, creating two new siRNAs with mis-
matches in the duplex. One of these siRNAs had a wobble
only in the siRNA duplex (dw) while the other also had a
wobble against the mRNA target (ww) (Figure 5B).
This strategy should allow for individual evaluation of the
contribution from wobbles in the siRNA duplex and the wob-
bles in the siRNA:mRNA interaction. In three cases (RMC661
dw, RMC686 dw and RMC869 dw), a wobble in the siRNA
duplex (dw) improved the silencing activity (Figure 5C). In
several other cases (RAC190 dw, RAC457 dw, RMC627 dw
and RMC821 dw), there was little or no effect. In all cases, the
siRNA:mRNA wobble (w) resulted in improved activities as
compared with the dw. Thus, there is a signiﬁcant, and inde-
pendent, siRNA:mRNA wobble improvement effect.
We further expanded our study by including siRNAs char-
acterized with a wobble both in the duplex and against the
mRNA (ww, Figure 5B). Consistent with wobble versions and
duplex wobble versions, these ww-versions were in some
cases stronger than wobble versions and in other cases weaker,
again arguing for two independent effects (Figure 5C).
A hard mutation at the ultimate 50 antisense end of
RMC845i (wt) was included to further test the alternative
explanation of duplex mismatch stimulation. The A:G mis-
match introduced at the siRNA:mRNA interaction (RMC845
m) resulted in a considerable loss of activity (Figure 5C). The
corresponding mismatch in the siRNA duplex (dm) was
tolerated without gain or loss of activity. This supports our
conclusion that duplex mismatches do not consistently
improve an siRNA.
However, the version with a mismatch both in the duplex
and against the mRNA target (RMC845 mm), was improved
compared with the mutated version (RMC845 m) (Figure 5C),
thus balancing the damage caused by the hard mutation. We
note that the wobble improvement of our best candidate
RAC937i was very modest,and speculate that already superior
siRNA candidates might not be further improved by this
approach.
The murine Aqp4 gene has 92% sequence identity to the
siRNA target area of rat Aqp4. This allowed us to further test
wobble-stimulation in another experimental system as six of
the siRNAs had perfect complementarity to the mouse
sequence. These six siRNAs were tested against a mouse
pmuAqp4-Luc construct. Again, the terminal siRNA:mRNA
wobble improved the siRNAs in all experiments (Figure 5D).
Signiﬁcantly, wobble mutations (w, ww and dw) of one rather
weak siRNA candidate (RMC686i), and of one intermediate
candidate (RMC869i), improved their activity to the level of
our best mouse siRNA candidate RMC845i.
DISCUSSION
RNAi shows tremendous potential as a tool for targeted gene
silencing and this mechanism was initially considered to be
sequence speciﬁc (17). Recent studies have questioned the
requirement of absolute sequence complementarity between
the siRNA and the target mRNA. These studies have been
based on the introduction of a series of mutations in the
siRNAs (5,6) or on genome-wide transcription proﬁling by
microarray analysis (14,16). However, the microarray studies
have not been entirely consistent (15,17), calling for further
investigations of the mechanisms underlying tolerance of
siRNA mutations.
Risk assessment for off-target siRNA silencing has been
evaluated by computational tools, with respect to commonly
used siRNAs and transcriptome data in humans (15) and in
Caenorhabditis elegans and Schizosaccharomyces pombe
(29). That mismatches between the siRNA and the mRNA
target can be tolerated by the RNAi machinery is now gen-
erally accepted. Our present study shows that wobble muta-
tions in the central part of the antisense strand cause a
pronounced decrease in activity, while mutations in the 50
and 30ends are well tolerated. This has implication for
algorithms used in design of speciﬁc and highly active
siRNAs. Notably, the present study adds to previous evidence
suggesting that there is no absolute speciﬁcity of siRNAs. This
implies that general rules for assessing siRNA activity may
have to be abandoned in favor of a case-to-case analysis of
individual siRNAs.
A major ﬁnding in the present study is that wobble muta-
tions, relative to the mRNA target, not only can be tolerated,
but can enhance activity if directed to the 50 end. These results
were consistent with nine different siRNAs against rat Aqp4,
and replicated with mouse Aqp4. The mechanistic basis of this
phenomenon isunknown, butmightreﬂect the preferences and
structural characteristics of the RISC complex.
During the revision of this work, a study was published that
estimated the mismatch vulnerability of siRNAs (30). This
study was based on a systematic analysis of the silencing
potential of an active siRNA on target mRNA carrying all
possible single-nucleotide mismatches. It was concluded
that the silencing potential was inﬂuenced both by the position
of the mismatched base and the identity of the nucleotides
forming the mismatch. The ﬁnding that central mutations give
decreased silencing activity, while peripheral mutations are
well tolerated, agrees well with the conclusion of the present
study.
Our ﬁndings have implications for future siRNA design
with respect to speciﬁcity and activity and may assume par-
ticular importance when the target mRNA offers a limited
choice of siRNA positions. Examples of such targets are tran-
scripts with point mutations, speciﬁc splice variants and junc-
tions in fusion oncogenes. In such cases, the introduction of
wobble mutations could provide a means to enhance the activ-
ity of the limited set of available siRNAs and thus extend the
siRNAs technology to a broader range of targets.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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